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a  b  s  t  r  a  c  t
In its broad  sense,  regeneration  refers  to  the renewal  of  lost  cells,  tissues  or organs  as  part  of the normal
life  cycle  (skin,  hair,  endometrium  etc.) or as part  of  an adaptive  mechanism  that  organisms  have  devel-
oped  throughout  evolution.  For  example,  worms,  starﬁsh  and  amphibians  have  developed  remarkable
regenerative  capabilities  allowing  them  to voluntarily  shed  body  parts,  in  a  process  called  autotomy,
only  to  replace  the  lost  parts  afterwards.  The  bizarre  myth  of the ﬁreproof  homicidal  salamander  that
can  survive  ﬁre  and  poison  apple  trees  has  persisted  until  the  20th  century.  Salamanders  possess  one
of  the most  robust  regenerative  machineries  in vertebrates  and  attempting  to  draw  lessons  from  limb
regeneration  in these  animals  and  extrapolate  the  knowledge  to mammals  is a  never-ending  endeavor.
Fibroblast  growth  factors  are  potent  morphogens  and  mitogens  that  are  highly  conserved  among  the
animal  kingdom.  These  growth  factors  play  key  roles in organogenesis  during  embryonic  development
as  well  as  homeostatic  balance  during  postnatal  life. In this  review,  we  provide  a  summary  about  the
current  knowledge  regarding  the involvement  of ﬁbroblast  growth  factor  signaling  in organ  regeneration
and  repair.  We  also shed  light  on the  use  of these  growth  factors  in  previous  and  current  clinical  trials  in
a  wide  array  of  human  diseases.
©  2015  Published  by  Elsevier  Ltd.
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1. Introduction
1.1. Historical background
Fibroblast growth factors (FGFs) constitute a family of evo-
lutionary conserved polypeptides that are involved in diverse
morphogenic and organogenic programs during embryonic devel-
opment as well as homeostatic balance during postnatal life.
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